Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma

This study is currently recruiting participants.

Study NCT00336063 Information provided by National Cancer Institute (NCI)

First Received: June 8, 2006 Last Updated: March 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)